(Q37988007)

26 August 2017

title

Cellular and physiological mechanisms of new-onset diabetes mellitus after solid organ transplantation (English)

1 reference

26 August 2017

main subject

organ transplantation

1 reference

M Dong

1

1 reference

26 August 2017

A K Parsaik

2

1 reference

26 August 2017

N L Eberhardt

3

1 reference

26 August 2017

A Basu

4

1 reference

26 August 2017

F G Cosio

5

1 reference

26 August 2017

Y C Kudva

6

1 reference

26 August 2017

publication date

1 July 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

29

1 reference

26 August 2017

issue

7

1 reference

26 August 2017

page(s)

e1-12

1 reference

New-onset diabetes after transplantation: a review of recent literature

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

New onset diabetes mellitus after solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Risk factors for development of new-onset diabetes mellitus in adult heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Pretransplant risk factors for new-onset diabetes mellitus after transplant in pediatric liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Posttransplantation diabetes: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Serum- and glucocorticoid-inducible kinase 1 (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Dexamethasone suppresses phospholipase C activation and insulin secretion from isolated rat islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Aged transgenic mice with increased glucocorticoid sensitivity in pancreatic beta-cells develop diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Recovery from diabetes in mice by beta cell regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Facilitating physiologic self-regeneration: a step beyond islet cell replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Calcineurin/NFAT signaling in the beta-cell: From diabetes to new therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Activation of the dual-leucine-zipper-bearing kinase and induction of beta-cell apoptosis by the immunosuppressive drug cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Calcineurin signaling regulates human islet {beta}-cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

{beta}-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Unique cellular and mitochondrial defects mediate FK506-induced islet β-cell dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Insulin release and suppression by tacrolimus, rapamycin and cyclosporin A are through regulation of the ATP-sensitive potassium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Tacrolimus impairment of insulin secretion in isolated rat islets occurs at multiple distal sites in stimulus-secretion coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS‐1E beta‐cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Mammalian target of rapamycin and diabetes: what does the current evidence tell us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Sirolimus is associated with new-onset diabetes in kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Rapamycin impairs metabolism-secretion coupling in rat pancreatic islets by suppressing carbohydrate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

mTORC1 activation regulates beta-cell mass and proliferation by modulation of cyclin D2 synthesis and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Polymorphisms of superoxide dismutase, glutathione peroxidase and catalase genes in patients with post-transplant diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Association of calpain-10 gene polymorphism and posttransplant diabetes mellitus in kidney transplant patients medicated with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Significant associations between CCL5 gene polymorphisms and post-transplantational diabetes mellitus in Korean renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

TCF7L2 polymorphism associates with new-onset diabetes after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Clinical relevance and prevalence of polymorphisms in CYP3A5 and MDR1 genes that encode tacrolimus biotransformation enzymes in liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Simultaneous islet and kidney transplantation in seven patients with type 1 diabetes and end-stage renal disease using a glucocorticoid-free immunosuppressive regimen with alemtuzumab induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

A Polymorphism in the Zinc Transporter Gene SLC30A8 Confers Resistance Against Posttransplantation Diabetes Mellitus in Renal Allograft Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03617.X

10.1111/J.1464-5491.2012.03617.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference